Sequential Treatment of Psoriasis With Traditional Chinese and Western Medicine
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Plaque Psoriasis
Related studies linked through entity extraction aliases.
A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering From Plaque Psoriasis Through Clinical Utility and Health Outcomes.
- Status
- UNKNOWN
- Phase
- NA
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)
- Status
- COMPLETED
- Phase
- PHASE2
Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Status
- RECRUITING
- Phase
- PHASE3
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Prevalence of Periodontitis in Patients With Plaque Psoriasis. A Cross-sectional Study
- Status
- UNKNOWN
- Phase
- N/A
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)
- Status
- COMPLETED
- Phase
- PHASE2
Guselkumab Immunogenetics
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis
- Status
- UNKNOWN
- Phase
- PHASE4
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
- Status
- RECRUITING
- Phase
- PHASE4
Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab
- Status
- TERMINATED
- Phase
- PHASE4